Kenya will pilot a life-saving drug ... for resource-strapped communities in Kenya because the drug is costly. According to National Aids and STIs Control Programme (Nascop) Programmes Manager ...
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
MIGORI, Kenya (AP) — As the coffin bearing the body of Rosebella Awuor was lowered into the grave, heart-wrenching sobs from mourners filled the air. Her sister Winnie Akinyi, the guardian to ...
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
The Kenya-based Universal Corporation Limited last year received the WHO’s approval to produce an antimalarial drug known as Spaq, a combination of sulfadoxine-pyrimethamine plus amodiaquine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results